Institution statistics

FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA - Spain 

Ranking results:

Past rankings:
2017
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Networking Rank (Reputation):500-600
2016
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:500-600
Total Number of Projects:600-700
Networking Rank (Reputation):600-700
2015
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:700-800
Total Number of Projects:800-900
Networking Rank (Reputation):800-900
Partner Constancy:700-800
Project Leadership Index:700-800
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2018-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 30
As coordinator: 2
As participant: 25
Sole participant: 3
Coordinator / Participant Ratio: 0.08*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2018 0 8.979.119 626.348 2
2017 0 36.744.950 2.904.606 5
2016 0 29.991.564 1.641.432 5
2015 0 40.497.896 816.006 4
2014 173.371 3.687.558 400.052 1 1
2013 100.000 9.306.780 552.457 1 3
2012 6.554.746 21.822.236 2.807.535 2 3
2011 354.900 0 224.700 1
2008 0 3.925.000 997.455 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE7
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS5
KING'S COLLEGE LONDON5
SERVICIO MADRILENO DE SALUD5
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER4
STICHTING KATHOLIEKE UNIVERSITEIT4
TARTU ULIKOOL4
UNIVERSITAETSKLINIKUM HEIDELBERG4
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUS MAXIMILIANS UNIVERSITAT4
UNIVERSITAT DE BARCELONA4
UNIVERSITY COLLEGE LONDON4
UNIVERSITY OF BERGEN4
ACADEMISCH ZIEKENHUIS GRONINGEN3
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
CONCENTRIS RESEARCH MANAGEMENT3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
KAROLINSKA INSTITUTE3
KATHOLIEKE UNIVERSITEIT LEUVEN3
STROKE ALLIANCE FOR EUROPE3
THE UNIVERSITY OF NOTTINGHAM3
UNIVERSITA DEGLI STUDI DI PADOVA3
UNIVERSITAET ULM3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITY OF BOLOGNA3
UNIVERSITY OF GLASGOW3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
CENTRE HOSPITALIER SAINT ANNE DE PARIS2
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE2
CENTRO DE INVESTIGACION BIOMEDICA EN RED2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
FAKULTNI NEMOCNICE U SV ANNY V BRNE2
FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
FUNDACION IMDEA NANOCIENCIA2
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O2
HOSPICES CIVILS DE LYON2
INSTITUT CATALA DE LA SALUT2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT2
KARLSRUHER INSTITUT FUER TECHNOLOGIE2
MEDIZINISCHE HOCHSCHULE HANNOVER2
NATIONAL STROKE RESEARCH INSTITUTE2
OSPEDALE PEDIATRICO BAMBINO GESU2
PROGENIKA BIOPHARMA2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
REGION HOVEDSTADEN2
SERVICIO ANDALUZ DE SALUD2
STICHTING KARAKTER2
TECHNISCHE UNIVERSITAET DRESDEN2
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK2
THE UNIVERSITY OF EDINBURGH2
UNIVERSITA VITA SALUTE SAN RAFFAELE2
UNIVERSITAET BERN2
UNIVERSITY OF BIRMINGHAM2
UNIVERSITY OF DUNDEE2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF LEICESTER2
VASTRA GOTALANDS LANS LANDSTING2
ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT2
A2F ASSOCIATES LIMITED1
AALTOKORKEAKOULUSAATIO1
AARDEX GROUP1
ABO AKADEMI1
ACADEMISCH ZIEKENHUIS LEIDEN1
ACONDICIONAMIENTO TARRASENSE ASSOCIACION1
ADD INFORMATION SERVICES1
AIBILII ASSOCIACAO DE APOIOAO INSTITUTO BIOMEDICO DE INVESTIGACAO DA LUZ E IMAGEM1
ALFA WASSERMANN1
ALPHA BIORESEARCH SL1
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA1
ALZHEIMER EUROPE1
ANAXOMICS BIOTECH S L1
ASDM CONSULTING1
ASPHALION SL1
ASSOCIATION GROUPE ESSEC1
ASTON UNIVERSITY1
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO1
AZIENDA OSPEDALIERA DI PERUGIA1
BAR ILAN UNIVERSITY1
BASILEA PHARMACEUTICA INTERNATIONAL1
BATAVIA BIOSCIENCES BV1
BAYERISCHE JULIUSMAXIMILIANS UNIVERSITAT WURZBURG1
BCN PEPTIDES1
BELFAST HEALTH AND SOCIAL CARE TRUST1
BIOPRAXIS RESEARCH AIE1
BRAINGAZE SL1
CAMBRIDGE NANOMATERIALS TECHNOLOGY1
CAMPDEN AND CHORLEYWOOD FOOD RESEARCH ASSOCIATION1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE BESANCON1
CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE1
CHARITE ? UNIVERSITAETSMEDIZIN BERLIN1
CHEMICELL1
CHU COTE DE NACRE CAEN1
CHU HOPITAUX DE BORDEAUX1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CONSORCIO DE APOYO A LA INVESTIGACION BIOMEDICA EN RED1
DEMOCRITUS UNIVERSITY OF THRACE1
Constancy:

Total number of partners:381

Partner loyalty:
Frequent Partner: (> 2 projects): 93
Rare Partner: 288

Frequent / Rare Partner Ratio: 0.32

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES8
RTD HORIZONTAL TOPICS4
SOCIAL AND ECONOMIC CONCERNS4
INDUSTRY AND TECHNOLOGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2018-10-01Evolvable platform for programmable nanoparticle-based cancer therapies EVO-NANOparticipant2.988.6597
2018-01-01Stem-cell based gene therapy for recombination deficient SCID (RECOMB) RECOMBparticipant5.990.46017
2017-12-01PREvention of STroke in Intracerebral hemorrhaGE survivors with Atrial Fibrillation PRESTIGE-AFparticipant6.958.89612
2017-10-01Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration nTRACKparticipant6.863.86512
2017-09-01Effects of Nutrition and Lifestyle on Impulsive, Compulsive, and Externalizing behaviours Eat2beNICEparticipant11.144.56218
2017-01-01Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial PROOFparticipant5.778.82712
2017-01-01SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS LIVERHOPEparticipant5.998.80016
2016-12-08Models Of Patient Engagement for Alzheimer’s Disease MOPEADparticipant2.043.00012
2016-04-01Remote Assessment of Disease and Relapse in Central Nervous System Disorders RADAR-CNSparticipant11.000.00019
2016-04-01Nanomedicine upscaling for early clinical phases of multimodal cancer therapy NoCanTherparticipant7.113.77911
2016-01-01Brain injury and trauma monitoring using advanced photonics BitMapparticipant3.835.76411
2016-01-01Comorbid Conditions of Attention deficit / hyperactivity disorder CoCAparticipant5.999.02117
2015-09-01REgenerative Stem cell therapy for STroke in Europe RESSTOREparticipant6.338.25930
2015-08-01iABC Programme IABC PROGRAMMEparticipant24.331.60922
2015-05-01Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease. CARBALIVEparticipant5.913.08014
2015-01-01Mastering skills in the training Network for attention deficit hyperactivity and autism spectrum Disorders MiNDparticipant3.914.94812
2014-04-01Unraveling metabolic settings and targeting metabolic enzymes with selective lethality in BRAF and NRAS mutant melanoma tumors METABOSETcoordinator173.3711
2014-02-01European Training in Neural Regulation of Intestinal Function NEUROGUTparticipant3.687.55812
2013-11-01Aggression subtyping for improved insight and treatment innovation in psychiatric disorders AGGRESSOTYPEparticipant6.000.00023
2013-11-01PREventive Care Infrastructure based On Ubiquitous Sensing PRECIOUSparticipant2.808.9998
2013-10-01New epigenetic therapy for high-risk neuroblastoma MIRNATHERAPYNBLcoordinator100.0001
2013-09-01Multicentre Preclinical Animal Research Team MULTI-PARTparticipant497.78112
2012-11-01Best EScalation Treatment in Multiple Sclerosis (MS) BEST MSparticipant4.880.5755
2012-09-01INCOMING FELLOWSHIPS BIOMEDICINE INSTITUT DE RECERCA VALL D’HEBRON INCOMEDcoordinator555.9841
2012-03-01European Consortium for the Early Treatment of Diabetic Retinopathy EUROCONDORcoordinator5.998.76218
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1participant10.941.66538
2012-01-01Early Prevention of Diabetes Complications in people with Hyperglycaemia in Europe E-PREDICEparticipant5.999.99635
2011-08-01PROTEOMIC IDENTIFICATION OF BIOMARKERS IN BIOFLUIDS AND IN PRECLINICAL MODELS FOR THE EARLY DIAGNOSIS AND PROGNOSIS OF CANCER (PROT*BIO*FLUID) PROTBIOFLUIDcoordinator354.9002
2008-09-15United Europeans for the development of pharmacogenomics in multiple sclerosis UEPHA-MSparticipant2.359.00011
2008-08-01Molecular Mechanisms of Glioma Genesis and Progression GLIOMAparticipant1.566.0002
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: